USC logo
University of Southern California
PIBBS Online ApplicationPIBBS CalendarContact PIBBSPIBBS Faculty DirectoryPIBBS Site Index
PIBBS Home PageFaculty ResearchFaculty DirectoryPhD ProgramsOnline Application
Research Centers and Institutes Faculty Research Support PIBBS Faculty in the News


Zoltan A. Tokes

Professor

Biochemistry and Molecular Biology
Keck School of Medicine
USC / Norris Comprehensive Cancer Center

Send E-mail to:   ztokes@usc.edu 
Telephone: 323-224-7775Fax: 323-224-7679
Office: CRL 102Mail Code: 9270 HSC

Education:
PhD 1970 - California Institute of Technology

Research Topics: Developmental Biology, Cell Cycle, Growth & Proliferation, Signal Transduction

Click here for:PubMed Search NIH GrantsSearch USC for Professor Tokes

See also:     All USC Research GrantsAll HSC Research Grants

Research Description

Investigations in our laboratory focus on two converging topics. First, we want to study the dynamic events which are involved in the maintenance and remodeling of three-dimensional cellular networks. Second, we want to find new methods by which to deliver biologically active compounds into specific tissue compartments to re-establish regular tissue architecture.

A gradual breakdown of tissue structures occurs during the progressive growth of cancer. Profound synaptic rearrangements take place during memory consolidation in the central nervous system, and a striking destruction of tissue architecture is observed in the brain with aging, especially in patients with AlzheimerŐs disease. Our research focuses on proteinases and their inhibitors since all of these events are influenced by their availability. Both metastatic cancer cells and invading nerve growth cones use matrix metalloproteinases, MMPs, capable of degrading tissue matrix components. We discovered that hippocampal neurons from Alzheimer patients express high amounts of inactive MMPs, and hypothesize that their activation may be blocked by excess inhibitors. Of interest is our observation that activated MMPs are capable of degrading amyloid peptides which would otherwise accumulate in the brain as insoluble deposits in the senile plaques. This finding also suggests that the activation of MMPs would result in more efficient destruction of amyloid peptides and reduce their accumulation in senile plaques. Consequently, the delivery of activating agents, or other biologically relevant compounds, to the brain may have therapeutic significance. Quantitation of MMP-produced fragments in the spinal fluid may provide diagnostic information. The possibility that measurement of MMP-produced amyloid fragments in the spinal fluid may provide diagnostic information is under investigation.

In situ hybridization with RNA-probe for MMP shows their synthesis in hippocampal neurons of AlzheimerŐs patients. Immunohistochemistry shows the accumulation of protease inhibitor, alpha-1-antichymotrypsin, in the same neurons.



10 Selected Publications:
Click here to view all the publications for this faculty

Lim GP,Russell MJ,Cullen MJ,Tökés ZA - Matrix metalloproteinases in dog brains exhibiting Alzheimer-like characteristics. - J Neurochem [1997] Apr;68(4):1606-11 PubMed

Backstrom JR,Lim GP,Cullen MJ,Tökés ZA - Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). - J Neurosci [1996] Dec 15;16(24):7910-9 PubMed

Lim GP,Backstrom JR,Cullen MJ,Miller CA,Atkinson RD,Tökés ZA - Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. - J Neurochem [1996] Jul;67(1):251-9 PubMed

Backstrom JR,Tökés ZA - The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. - J Neurochem [1995] Mar;64(3):1312-8 PubMed

Neri A,Bohoslawec O,Anderson TD,Tokes ZA - Differential release of active proteinase inhibitors by two rat mammary adenocarcinoma variants possessing different metastatic potentials. - Cancer Res [1991] Feb 15;51(4):1318-25 PubMed

Backstrom JR,Miller CA,Tökés ZA - Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. - J Neurochem [1992] Mar;58(3):983-92 PubMed

DeLeve LD,Wang X,Kanel GC,Ito Y,Bethea NW,McCuskey MK,Tokes ZA,Tsai J,McCuskey RS - Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. - Hepatology [2003] Oct;38(4):900-8 PubMed

Deleve LD,Wang X,Tsai J,Kanel G,Strasberg S,Tokes ZA - Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. - Gastroenterology [2003] Sep;125(3):882-90 PubMed

Ren S,Tokes ZA,Csipke C,Zhou B,Yen Y,Lien EJ - Inhibition of tumor cell growth by Schiff bases of hydroxysemicarbazide. - Anticancer Res [2001] Sep-Oct;21(5):3445-51 PubMed

Ren S,Wang R,Komatsu K,Bonaz-Krause P,Zyrianov Y,McKenna CE,Csipke C,Tokes ZA,Lien EJ - Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of new Schiff bases of hydroxysemicarbazide as potential antitumor agents. - J Med Chem [2002] Jan 17;45(2):410-9 PubMed


NCBI Disclaimers and copyright notice
Last updated: Monday August 10th 10:10am 2009

Return to   PIBBS home page  |  Research Topics page
  For more information contact the PIBBS Program

University of Southern California
1975 Zonal Avenue KAM-B16
Los Angeles, California 90089-9031
323-442-1609 (voice) / 323-442-1199 (fax)
E-mail: pibbs@usc.edu
 
 
© 1998-2008 The University of Southern California